Related Experiment Videos
Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride
J O Rinne1, J Hietala, U Ruotsalainen
1Department of Neurology, University of Turku, Finland.
Summary
Aging reduces dopamine D2 receptors in the human brain. This study found a significant age-dependent decline in striatal D2 receptor density, potentially impacting motor control in older adults.
Area of Science:
- Neuroscience
- Radiochemistry
- Gerontology
Background:
- Dopamine D2 receptors are crucial for motor control and cognitive functions.
- The aging process is associated with changes in neurotransmitter systems, including dopaminergic pathways.
- Understanding age-related alterations in dopamine D2 receptors is vital for explaining motor deficits in aging.
Purpose of the Study:
- To investigate the effect of age on the density and binding characteristics of striatal dopamine D2 receptors in healthy human subjects.
- To quantify the relationship between age and the maximal number of dopamine D2 receptors (Bmax) and their dissociation constant (Kd).
Main Methods:
- Positron Emission Tomography (PET) imaging was employed using the radioligand [11C]raclopride.
- Twenty-one healthy volunteers across a wide age range (20-81 years) participated in the study.
- Scatchard analysis was used to calculate Bmax and Kd from equilibrium PET scan data with varying radioligand specific activities.
Main Results:
- A significant age-dependent decline in the Bmax of striatal dopamine D2 receptors was observed (r = -0.49; p = 0.02).
- The dissociation constant (Kd) for dopamine D2 receptors remained unchanged with age.
- This indicates a loss in the number of available D2 receptors rather than a change in their binding affinity.
Conclusions:
- The human brain experiences an age-related reduction in the number of striatal dopamine D2 receptors.
- This decrease in dopamine D2 receptor density may contribute to age-associated changes in motor function and extrapyramidal symptoms.
- Further research into the nigrostriatal dopaminergic system's aging process is warranted.